PRECIGEN, INC. Increase (Decrease) in Due to Related Parties, Current
PRECIGEN, INC. (PGEN) reported Increase (Decrease) in Due to Related Parties, Current of $0 for the 9-month period ending 2023-09-30, per its 10-Q filed 2023-11-09.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDueToRelatedPartiesCurrent · last filed 2023-11-09
- PRECIGEN, INC. increase (decrease) in due to related parties, current for the quarter ending 2023-09-30 was $0.00.
- PRECIGEN, INC. increase (decrease) in due to related parties, current for the quarter ending 2023-06-30 was $0.00.
- PRECIGEN, INC. increase (decrease) in due to related parties, current for the quarter ending 2023-03-31 was $0.00.
- PRECIGEN, INC. increase (decrease) in due to related parties, current for the quarter ending 2022-12-31 was $0.00, a 100.00% decline year-over-year.
- PRECIGEN, INC. increase (decrease) in due to related parties, current for fiscal 2022 was -$78.00K, a 1075.00% decline from fiscal 2021.
- PRECIGEN, INC. increase (decrease) in due to related parties, current for fiscal 2021 was $8.00K.
- PRECIGEN, INC. increase (decrease) in due to related parties, current for fiscal 2020 was -$33.00K, a 173.33% decline from fiscal 2019.
- PRECIGEN, INC. increase (decrease) in due to related parties, current for fiscal 2019 was $45.00K.
| Period end | Increase (Decrease) in Due to Related Parties, Current 3 month | Increase (Decrease) in Due to Related Parties, Current 6 month | Increase (Decrease) in Due to Related Parties, Current 9 month | Increase (Decrease) in Due to Related Parties, Current 12 month |
|---|---|---|---|---|
| 2023-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | $0.00 10-Q · filed 2023-11-09 | $0.00 derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | $0.00 10-Q · filed 2023-08-09 | $0.00 derived: sum of 3 quarters · filed 2023-08-09 | $0.00 derived: sum of 4 quarters · filed 2023-11-09 |
| 2023-03-31 | $0.00 10-Q · filed 2023-05-10 | $0.00 derived: sum of 2 quarters · filed 2023-05-10 | $0.00 derived: sum of 3 quarters · filed 2023-11-09 | -$77.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $0.00 derived: sum of 2 quarters · filed 2023-11-09 | -$77.00K derived: sum of 3 quarters · filed 2023-11-09 | -$78.00K 10-K · filed 2023-03-06 |
| 2022-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-09 | -$77.00K derived: sum of 2 quarters · filed 2023-11-09 | -$78.00K 10-Q · filed 2023-11-09 | -$74.00K derived: sum of 4 quarters · filed 2023-11-09 |
| 2022-06-30 | -$77.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-09 | -$78.00K 10-Q · filed 2023-08-09 | -$74.00K derived: sum of 3 quarters · filed 2023-08-09 | -$73.00K derived: sum of 4 quarters · filed 2023-08-09 |
| 2022-03-31 | -$1.00K 10-Q · filed 2023-05-10 | $3.00K derived: sum of 2 quarters · filed 2023-05-10 | $4.00K derived: sum of 3 quarters · filed 2023-05-10 | -$26.00K derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $4.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | $5.00K derived: sum of 2 quarters · filed 2023-03-06 | -$25.00K derived: sum of 3 quarters · filed 2023-03-06 | $8.00K 10-K · filed 2023-03-06 |
| 2021-09-30 | $1.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | -$29.00K derived: sum of 2 quarters · filed 2022-11-09 | $4.00K 10-Q · filed 2022-11-09 | -$334.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-06-30 | -$30.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | $3.00K 10-Q · filed 2022-08-08 | -$335.00K derived: sum of 3 quarters · filed 2023-03-06 | -$153.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2021-03-31 | $33.00K 10-Q · filed 2022-05-09 | -$305.00K derived: sum of 2 quarters · filed 2023-03-06 | -$123.00K derived: sum of 3 quarters · filed 2023-03-06 | -$87.00K derived: sum of 4 quarters · filed 2023-03-06 |
| 2020-12-31 | -$338.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | -$156.00K derived: sum of 2 quarters · filed 2023-03-06 | -$120.00K derived: sum of 3 quarters · filed 2023-03-06 | -$33.00K 10-K · filed 2023-03-06 |
| 2020-09-30 | $182.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-08 | $218.00K derived: sum of 2 quarters · filed 2021-11-08 | $305.00K 10-Q · filed 2021-11-08 | $312.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-06-30 | $36.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-09 | $123.00K 10-Q · filed 2021-08-09 | $130.00K derived: sum of 3 quarters · filed 2022-03-01 | $101.00K derived: sum of 4 quarters · filed 2022-03-01 |
| 2020-03-31 | $87.00K 10-Q · filed 2021-05-10 | $94.00K derived: sum of 2 quarters · filed 2022-03-01 | $65.00K derived: sum of 3 quarters · filed 2022-03-01 | -$1.78M derived: sum of 4 quarters · filed 2022-03-01 |
| 2019-12-31 | $7.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | -$22.00K derived: sum of 2 quarters · filed 2022-03-01 | -$1.87M derived: sum of 3 quarters · filed 2022-03-01 | $45.00K 10-K · filed 2022-03-01 |
| 2019-09-30 | -$29.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | -$1.88M derived: sum of 2 quarters · filed 2020-11-09 | $38.00K 10-Q · filed 2020-11-09 | $153.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | -$1.85M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-10 | $67.00K 10-Q · filed 2020-08-10 | $182.00K derived: sum of 3 quarters · filed 2021-03-01 | $214.00K derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $1.92M 10-Q · filed 2020-05-11 | $2.03M derived: sum of 2 quarters · filed 2021-03-01 | $2.06M derived: sum of 3 quarters · filed 2021-03-01 | $2.03M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $115.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $147.00K derived: sum of 2 quarters · filed 2021-03-01 | $113.00K derived: sum of 3 quarters · filed 2021-03-01 | -$52.00K 10-K · filed 2021-03-01 |
| 2018-09-30 | $32.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-12 | -$2.00K derived: sum of 2 quarters · filed 2019-11-12 | -$167.00K 10-Q · filed 2019-11-12 | -$670.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-06-30 | -$34.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-09 | -$199.00K 10-Q · filed 2019-08-09 | -$702.00K derived: sum of 3 quarters · filed 2020-03-02 | -$630.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2018-03-31 | -$165.00K 10-Q · filed 2019-05-09 | -$668.00K derived: sum of 2 quarters · filed 2020-03-02 | -$596.00K derived: sum of 3 quarters · filed 2020-03-02 | -$473.00K derived: sum of 4 quarters · filed 2020-03-02 |
| 2017-12-31 | -$503.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-02 | -$431.00K derived: sum of 2 quarters · filed 2020-03-02 | -$308.00K derived: sum of 3 quarters · filed 2020-03-02 | -$147.00K 10-K · filed 2020-03-02 |
| 2017-09-30 | $72.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-08 | $195.00K derived: sum of 2 quarters · filed 2018-11-08 | $356.00K 10-Q · filed 2018-11-08 | $187.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-06-30 | $123.00K derived: 10-Q 6 month − 10-Q/A 3 month · filed 2018-08-13 | $284.00K 10-Q · filed 2018-08-13 | $115.00K derived: sum of 3 quarters · filed 2019-03-01 | $263.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2017-03-31 | $161.00K 10-Q/A · filed 2018-08-13 | -$8.00K derived: sum of 2 quarters · filed 2019-03-01 | $140.00K derived: sum of 3 quarters · filed 2019-03-01 | $263.00K derived: sum of 4 quarters · filed 2019-03-01 |
| 2016-12-31 | -$169.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | -$21.00K derived: sum of 2 quarters · filed 2019-03-01 | $102.00K derived: sum of 3 quarters · filed 2019-03-01 | $310.00K 10-K · filed 2019-03-01 |
| 2016-09-30 | $148.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | $271.00K derived: sum of 2 quarters · filed 2017-11-09 | $479.00K 10-Q · filed 2017-11-09 | $482.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-06-30 | $123.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $331.00K 10-Q · filed 2017-08-09 | $334.00K derived: sum of 3 quarters · filed 2018-03-01 | -$57.10M derived: sum of 4 quarters · filed 2018-03-01 |
| 2016-03-31 | $208.00K 10-Q · filed 2017-05-10 | $211.00K derived: sum of 2 quarters · filed 2018-03-01 | -$57.23M derived: sum of 3 quarters · filed 2018-03-01 | $300.00K derived: sum of 4 quarters · filed 2018-03-01 |
| 2015-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-01 | -$57.43M derived: sum of 2 quarters · filed 2018-03-01 | $92.00K derived: sum of 3 quarters · filed 2018-03-01 | -$64.00K 10-K · filed 2018-03-01 |
| 2015-09-30 | -$57.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $89.00K derived: sum of 2 quarters · filed 2016-11-09 | -$67.00K 10-Q · filed 2016-11-09 | -$1.01M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-06-30 | $57.53M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $57.37M 10-Q · filed 2016-08-09 | $56.42M derived: sum of 3 quarters · filed 2017-03-01 | $56.24M derived: sum of 4 quarters · filed 2017-03-01 |
| 2015-03-31 | -$156.00K 10-Q · filed 2016-05-10 | -$1.10M derived: sum of 2 quarters · filed 2017-03-01 | -$1.28M derived: sum of 3 quarters · filed 2017-03-01 | -$1.25M derived: sum of 4 quarters · filed 2017-03-01 |
| 2014-12-31 | -$945.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01 | -$1.13M derived: sum of 2 quarters · filed 2017-03-01 | -$1.09M derived: sum of 3 quarters · filed 2017-03-01 | -$1.14M 10-K · filed 2017-03-01 |
| 2014-09-30 | -$182.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | -$145.00K derived: sum of 2 quarters · filed 2015-11-09 | -$192.00K 10-Q · filed 2015-11-09 | -$221.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $37.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | -$10.00K 10-Q · filed 2015-08-10 | -$39.00K derived: sum of 3 quarters · filed 2016-02-29 | $85.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | -$47.00K 10-Q · filed 2015-05-11 | -$76.00K derived: sum of 2 quarters · filed 2016-02-29 | $48.00K derived: sum of 3 quarters · filed 2016-02-29 | -$252.00K derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | -$29.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $95.00K derived: sum of 2 quarters · filed 2016-02-29 | -$205.00K derived: sum of 3 quarters · filed 2016-02-29 | $6.00K 10-K · filed 2016-02-29 |
| 2013-09-30 | $124.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-13 | -$176.00K derived: sum of 2 quarters · filed 2014-11-13 | $35.00K 10-Q · filed 2014-11-13 | $104.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-06-30 | -$300.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-14 | -$89.00K 10-Q · filed 2014-08-14 | -$20.00K derived: sum of 3 quarters · filed 2015-03-02 | -$20.00K derived: sum of 4 quarters · filed 2015-03-02 |
| 2013-03-31 | $211.00K 10-Q · filed 2014-05-09 | $280.00K derived: sum of 2 quarters · filed 2015-03-02 | $280.00K derived: sum of 3 quarters · filed 2015-03-02 | |
| 2012-12-31 | $69.00K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-02 | $69.00K derived: sum of 2 quarters · filed 2015-03-02 | -$180.00K 10-K · filed 2015-03-02 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q/A 6 month · filed 2013-11-07 | -$249.00K 10-Q · filed 2013-11-07 | ||
| 2012-06-30 | -$249.00K 10-Q/A · filed 2013-10-21 | |||
| 2011-12-31 | -$215.00K 10-K · filed 2014-03-31 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NewAmsterdam Pharma Co N.V. (NAMS) | $2.719B | -15.37 | |
| MBX Biosciences, Inc. (MBX) | United States | $2.664B | -25.36 |
| Disc Medicine, Inc. (IRON) | United States | $2.553B | -11.40 |
| Immunome Inc. (IMNM) | United States | $2.538B | -9.45 |
| SUPERNUS PHARMACEUTICALS, INC. (SUPN) | United States | $2.517B | -24.63 |
| Nurix Therapeutics, Inc. (NRIX) | United States | $2.457B | -5.39 |
| Dyne Therapeutics, Inc. (DYN) | United States | $3.084B | -7.09 |
| SELLAS Life Sciences Group, Inc. (SLS) | United States | $2.420B | -91.87 |
| uniQure N.V. (QURE) | $2.416B | -4.93 | |
| Vera Therapeutics, Inc. (VERA) | United States | $2.402B | -7.67 |